Skip to main content

Ethical Issues in Clinical Genetics and Genomics

  • Chapter
  • First Online:
Genomic Applications in Pathology

Abstract

This chapter sets out crucial ethical and legal issues raised both by existing targeted genetic testing, and, more importantly, by the rising tide of broader genomic tests, such as whole-genome sequencing (WGS). Clinical genetic testing has been available for over 40 years, but not all the concerns have been resolved. The chapter discusses those concerns in traditional targeted testing in five categories: the decision whether to test, the tests’ accuracy, conveying the results to patients, direct-to-consumer testing, and a variety of other concerns. It then discusses intermediate forms of testing, tests such as multiplex tandem mass spectrometry and SNP arrays, that do not provide information about only a handful of genetic variants, but also do not provide powerful information about many disease-linked variants. It ends by discussing how WGS and other “broad” tests will greatly exacerbate the ethical and legal problems of existing testing methods, particularly with respect to accuracy, conveying results, and confidentiality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Am College Med Genet (2008) ACMG statement on direct-to-consumer genetic testing. https://www.acmg.net/docs/ACMG_Statement_on_DTC_4.07.08.pdf

  2. Am College Med Genet (2012) Points to consider in the clinical application of genomic sequencing. http://www.acmg.net/StaticContent/PPG/Clinical_Application_of_Genomic_Sequencing.pdf. Accessed 5 Jul 2013

  3. Am College Med Genet (2013) Incidental findings in clinical genomics: a clarification.www.acmg.net/docs/Incidental_Findings_in_Clinical_Genomics_A_Clarification.pdf. Accessed 5 Jul 2013.

  4. Ashley EA et al. Clinical assessment incorporating a personal genome. Lancet. 2010;375:1525–35.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Association for Molecular Pathology v. Myriad Genetics, Inc. 2013. _U.S. __, 133 S.Ct. 1958.

    Google Scholar 

  6. Biesecker LG. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet Med. 2012;14:393–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Clayton EW et al. Managing incidental genomic findings: legal obligations of clinicians. Genet Med. 2013;15:624–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. DNA DTC. Products. 2013. http://www.dnadtc.com/. Accessed 2 Sept 2013.

  9. Genome Web. Lab group submits citizen petition against FDA regulation of lab developed tests. 2013. http://www.genomeweb.com/print/1237821?hq_e=el&hq_m=1588054&hq_l=1&hq_v=162223e076. Accessed 24 Aug 2013.

  10. Genome Web. Members of Congress Urge Obama Administration to Release FDA Draft Guidance on LDT Regulation. 2013. http://www.genomeweb.com/clinical-genomics/members-congress-urge-obama-administration-release-fda-draft-guidance-ldt-regula. Accessed 24 Aug 2013.

  11. Global Alliance. Creating a global alliance to enable responsible sharing of genomic and clinical data. 2013. http://www.broadinstitute.org/news/globalalliance. Accessed 2 Sept 2013.

  12. Government Accountability Office. Direct-to-consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices. Washington, DC: GAO; 2010.

    Google Scholar 

  13. Greely HT. “Genotype Discrimination”: the complex case for some legislative protection. Univ PA Law Rev. 2001;149:1483–505.

    Article  PubMed  CAS  Google Scholar 

  14. Greely HT. Human genomics research: new challenges for research ethics. Perspect Biol Med. 2001;44(2):221–9.

    Article  PubMed  CAS  Google Scholar 

  15. Greely HT. The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annu Rev Genomics Hum Genet. 2007;8:343–64.

    Article  PubMed  CAS  Google Scholar 

  16. Greely HT. Testing infant destinies. Nature. 2012;492:192.

    Article  Google Scholar 

  17. Green RC et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565–74.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  18. Green RC et al. Clinical genome sequencing. In: Ginsburg G, Willard H, editors. Genomic and personalized medicine. 2nd ed. San Diego: Elsevier; 2013. p.102–22.

    Google Scholar 

  19. Hayden EC. Geneticists push for global data sharing. Nature. 2013;498:16–7.

    PubMed  Google Scholar 

  20. Lam HY et al. Performance comparison of whole genome sequencing platforms. Nat Biotech. 2012;30:78–82.

    Article  CAS  Google Scholar 

  21. Manolio TA et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258–67.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mayer AN et al. A timely arrival for genomic medicine. Genet Med. 2011;13:195–6.

    Article  PubMed  Google Scholar 

  23. McGuire AL et al. Ethics and genomic incidental findings. Science. 2013;340:1047–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Ng PC et al. An agenda for personalized medicine. Nature. 2009;461:724–6.

    Article  PubMed  CAS  Google Scholar 

  25. Ormond KE et al. Challenges in the clinical application of whole-genome sequencing. Lancet. 2010;375:1749–51.

    Article  PubMed  Google Scholar 

  26. Ross LF et al. Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15:234–45.

    Article  PubMed  Google Scholar 

  27. Schrijver I et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the association for molecular pathology. J Mol Diagn. 2012;15:525–40.

    Article  Google Scholar 

  28. Timmermans S, Buchbinder M. Saving babies?: the consequences of newborn screening. Chicago: University of Chicago Press; 2012.

    Book  Google Scholar 

  29. van El CG et al. Whole-genome sequencing in health care: recommendations of the European Society of human genetics. Euro J Hum Gen. 2013;21:580–4.

    Google Scholar 

  30. Wolf SM et al. Patient autonomy and incidental findings in clinical genomics. Science. 2013;340:1049–50.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  31. Zettler PJ et al. 23andMe, the Food and Drug Administration, and the future of genetic testing. JAMA. 2014;174(4):493–4. doi:10.1001/jamainternmed.2013.14706.

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Greely, H.T. (2015). Ethical Issues in Clinical Genetics and Genomics. In: Netto, G., Schrijver, I. (eds) Genomic Applications in Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0727-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0727-4_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0726-7

  • Online ISBN: 978-1-4939-0727-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics